Key Stats
Key stats represent essential financial metrics and indicators used to evaluate a company's performance and potential investment opportunities.
Stock Score/grades
The Stock Score/Grades evaluate bankruptcy risk and assess the financial strength and fundamental health of a company
- Altman Z Score 12.79
- Piotroski Score 3.00
- Grade Buy
- Symbol (ORIC)
- Company ORIC Pharmaceuticals, Inc.
- Price $9.66
- Changes Percentage (1.9%)
- Change $0.18
- Day Low $8.96
- Day High $9.79
- Year High $16.65
ORIC Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, discovers and develops therapies for treatment of cancers in the United States. Its clinical stage product candidates include ORIC-533, an orally bioavailable small molecule inhibitor of CD73 being developed for resistance to chemotherapy- and immunotherapy-based treatment regimens; ORIC-944, an allosteric inhibitor of the polycomb repressive complex 2 for prostate cancer; and ORIC-114, a brain penetrant orally bioavailable irreversible inhibitor designed to selectively target epidermal growth factor receptor and human epidermal growth factor receptor 2 with high potency towards exon 20 insertion mutations. The company is also developing multiple discovery stage precision medicines targeting other cancer resistance mechanisms. It has a license and collaboration agreement with Voronoi Inc.; and a license agreement with Mirati Therapeutics, Inc. The company was incorporated in 2014 and is headquartered in South San Francisco, California.
- Last Earnings
- Ex-Dividend for 5/16 Dividend
- Dividend Payable
- Today N/A
- Next Earnings (Estimated) 11/05/2024
- Fiscal Year End N/A
- Average Stock Price Target $20.00
- High Stock Price Target $21.00
- Low Stock Price Target $7.00
- Potential Upside/Downside N/A
- Consensus Rating Sell
- Rating Score (0-4) N/A
- Research Coverage N/A
- EPS (Most Recent Fiscal Year) -$1.80
- Trailing P/E Ratio -4.91
- Forward P/E Ratio -4.91
- P/E Growth -4.91
- Net Income $-100,697,000
Income Statement
Quarterly
Annual
Latest News of ORIC
The Latest News section aggregates recent news posts from various news outlets, offering a comprehensive overview of the most recent developments related to the topic.
-
Trump and Harris make final pitch in Pennsylvania on eve of historic US vote
By Steve Holland and Nandita BosePITTSBURGH (Reuters) -Donald Trump and Kamala Harris both predicted victory as they campaigned across Pennsylvania on Monday in the final, frantic day of an exception...
By Reuters | 21 hours ago -
San Francisco mayoral candidate Mark Farrell agrees to historic campaign ethics fine
San Francisco mayoral candidate Mark Farrell faces a record ethics fine for violating campaign contribution limits. The settlement includes a $108,000 penalty for misuse of funds from a committee supp...
By CBS News | 23 hours ago -
New "terror bird" discovery reveals terrifying size of prehistoric predator
A recent study reported the discovery of a 12-million-year-old fossil of a massive prehistoric "terror bird" in South America. The fossil, found in Colombia, represents one of the largest known specie...
By Newsweek | 1 day ago
